{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:37:59Z","timestamp":1790800679781,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100008368","name":"Danish Rheumatism Association","doi-asserted-by":"publisher","award":["R163-A5661"],"award-info":[{"award-number":["R163-A5661"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008368","name":"Danish Rheumatism Association","doi-asserted-by":"publisher","award":["R155-A4747"],"award-info":[{"award-number":["R155-A4747"]}],"id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007605","name":"Aarhus University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate whether GCA is associated with increased all-cause and cause-specific mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A nationwide, population-based cohort study in Denmark using medical and administrative registries. GCA cases were defined as patients aged \u226550\u2009years from 1996\u20132018 with a first-time discharge diagnosis of GCA and \u22653 prescriptions for prednisolone within 6\u2009months following diagnosis. Each GCA patient was matched based on age, sex and calendar time to 10 persons without a history of GCA. Index date was the date for the third prednisolone prescription. We used a pseudo-observation approach to calculate all-cause and cause-specific mortality, adjusted risk differences (RDs) and relative risks (RRs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 9908 GCA patients and 98 204 persons from the general population. The median time for GCA patients to redeem the third prednisolone prescription was 74\u2009days [interquartile range (IQR: 49\u2013106)]. Among GCA patients, the overall mortality was 6.4% (95% CI: 5.9, 6.9) 1\u2009year after index date and 45% (95% CI: 44, 47) after 10\u2009years. Compared with the reference cohort, adjusted RDs and RRs of deaths in the GCA cohort were 2.2% (95% CI: 1.7, 2.7) and 1.49 (95% CI: 1.36, 1.64) after 1\u2009year, and 2.1% (95% CI: 1.0, 3.3) and 1.03 (95% CI: 1.00, 1.05) 10\u2009years after index date. GCA patients had a higher risk of death due to infectious, endocrine, cardiovascular and gastrointestinal diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>GCA is associated with increased all-cause mortality, particularly within the first year following the diagnosis. Cause-specific mortality indicates that mortality in GCA may in part be due to glucocorticoid-related complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab507","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T19:13:45Z","timestamp":1624043625000},"page":"1195-1203","source":"Crossref","is-referenced-by-count":33,"title":["All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-5769","authenticated-orcid":false,"given":"Philip","family":"Therkildsen","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Aarhus University Hospital"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit Dalsgaard","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"},{"name":"Department of Internal Medicine, Horsens Regional Hospital, Horsens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"de Thurah","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aarhus University Hospital"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ib T\u00f8nder","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aarhus University Hospital"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"N\u00f8rgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"},{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Aarhus University Hospital"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"2022030208051943600_keab507-B1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2012-202145","article-title":"Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis","volume":"73","author":"Mackie","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022030208051943600_keab507-B2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/M12-3046","article-title":"Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study","volume":"160","author":"Tomasson","year":"2014","journal-title":"Ann Intern Med"},{"key":"2022030208051943600_keab507-B3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12998\/wjcc.v3.i6.484","article-title":"Giant cell arteritis: current treatment and management","volume":"3","author":"Ponte","year":"2015","journal-title":"World J Clin Cases"},{"key":"2022030208051943600_keab507-B4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10654-016-0167-1","article-title":"Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study","volume":"31","author":"Movahedi","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2022030208051943600_keab507-B5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rinc\u00f3n","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2022030208051943600_keab507-B6","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"2022030208051943600_keab507-B7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/acr.22942","article-title":"Incidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period","volume":"69","author":"Catanoso","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2022030208051943600_keab507-B8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","article-title":"Mortality in patients with giant cell arteritis","volume":"54","author":"Baslund","year":"2015","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden","volume":"74","author":"Mohammad","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022030208051943600_keab507-B10","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","article-title":"Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis","volume":"72","author":"Kermani","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022030208051943600_keab507-B11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.24133","article-title":"Incidence trends and mortality of giant cell arteritis in Southern Norway","volume":"73","author":"Andersen","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2022030208051943600_keab507-B12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","article-title":"Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis","volume":"46","author":"Hill","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2022030208051943600_keab507-B13","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","volume":"59","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B14","doi-asserted-by":"crossref","first-page":"e001285","DOI":"10.1136\/rmdopen-2020-001285","article-title":"Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study","volume":"6","author":"Turkiewicz","year":"2020","journal-title":"RMD Open"},{"key":"2022030208051943600_keab507-B15","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B16","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/rheumatology\/kez568","article-title":"Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET\/CT as the reference","volume":"59","author":"Nielsen","year":"2020","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2022030208051943600_keab507-B18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2022030208051943600_keab507-B19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/CLEP.S258219","article-title":"Positive predictive value of the giant cell arteritis diagnosis in the Danish National Patient Registry: a validation study","volume":"12","author":"Hjort","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2022030208051943600_keab507-B20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Wallach Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022030208051943600_keab507-B21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2022030208051943600_keab507-B22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CLEP.S9908","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","volume":"2","author":"Erichsen","year":"2010","journal-title":"Clin Epidemiol"},{"key":"2022030208051943600_keab507-B23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S17901","article-title":"Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark","volume":"3","author":"Grann","year":"2011","journal-title":"Clin Epidemiol"},{"key":"2022030208051943600_keab507-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2022030208051943600_keab507-B25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0962280209105020","article-title":"Pseudo-observations in survival analysis","volume":"19","author":"Andersen","year":"2010","journal-title":"Stat Methods Med Res"},{"key":"2022030208051943600_keab507-B26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.semarthrit.2021.01.007","article-title":"Giant cell arteritis: a nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment","volume":"51","author":"Therkildsen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2022030208051943600_keab507-B27","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022030208051943600_keab507-B28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2022030208051943600_keab507-B29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13075-019-1945-4","article-title":"Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study","volume":"21","author":"Brekke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022030208051943600_keab507-B30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice","volume":"77","author":"Dejaco","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022030208051943600_keab507-B32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/key325","article-title":"Survival predictors in biopsy-proven giant cell arteritis: a northern Italian population-based study","volume":"58","author":"Macchioni","year":"2019","journal-title":"Rheumatology"},{"key":"2022030208051943600_keab507-B33","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022030208051943600_keab507-B34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2022030208051943600_keab507-B35","first-page":"S13","volume-title":"Clin Exp Rheumatol","author":"Pego-Reigosa","year":"2004"},{"key":"2022030208051943600_keab507-B36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjmed.2011.08.006","article-title":"Lifestyle risk factors predict disability and death in healthy aging adults","volume":"125","author":"Chakravarty","year":"2012","journal-title":"Am J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab507\/39303202\/keab507.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/1195\/42672346\/keab507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/3\/1195\/42672346\/keab507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:10:01Z","timestamp":1646208601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/3\/1195\/6308564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6,23]]},"published-print":{"date-parts":[[2022,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab507","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,6,23]]}}}